Personalized Anti-TNF Treatment for Inflammatory Bowel Disease
Part of Digestive system clinical trials.
This trial tests a personalized approach to starting anti-TNF therapy—a common treatment for inflammatory bowel disease (IBD)—in patients who have never taken it before. The goal is to help doctors choose the right anti-TNF medication and dose based on each patient's individual characteristics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Crohn's disease or ulcerative colitis (the two main types of inflammatory bowel disease)
- You have never taken an anti-TNF medication before
- Your disease is currently active, meaning you have moderate to significant symptoms
- Blood tests or stool tests show signs of inflammation (elevated CRP or calprotectin)
- You are able to understand the study and provide informed consent
- You are able to complete all study visits and procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at using precision medicine to treat inflammatory bowel disease (IBD) in people who are newly diagnosed or already being monitored. It aims to find better ways to manage the condition.
This study tests whether adding a diet and stress management program to standard advanced therapy helps people with active Crohn's disease or ulcerative colitis feel better. It combines lifestyle changes with new medications to improve treatment outcomes.
This trial looks at people with Crohn's disease or ulcerative colitis who have already tried and failed at least one advanced medication (like a biologic or small molecule drug). If you are starting a new advanced therapy, researchers will track how well it works for you.
This trial tests whether closely monitoring and adjusting infliximab (a biologic medicine) can help people hospitalized with a moderate-to-severe flare of Crohn's disease, ulcerative colitis, or unclassified inflammatory bowel disease who haven't gotten better with IV steroids. The goal is to improve treatment response and outcomes.
This trial tests new therapies for people with moderate to severe Crohn's disease or ulcerative colitis. It may help if your standard treatments aren't working well enough.
This trial compares two different ways to choose your Crohn's treatment: one based on a special test of your cells (epigenetic markers) and the other based on standard care. It aims to see which approach works better for people with moderate to severe Crohn's disease.
Hear when a new IBD (Inflammatory Bowel Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.